Exagen Inc. XGN Reportable Segment — Stock compensation
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s reportable segment — stock compensation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Exagen Inc.'s reportable segment — stock compensation?
- Exagen Inc. (XGN) reported reportable segment — stock compensation of $607K in Q1 2026.
- How has Exagen Inc.'s reportable segment — stock compensation changed year-over-year?
- Exagen Inc.'s reportable segment — stock compensation increased by 67.7% year-over-year, from $362K to $607K.
- What is the long-term trend for Exagen Inc.'s reportable segment — stock compensation?
- Over 2 years (2023 to 2025), Exagen Inc.'s reportable segment — stock compensation has grown at a -25.1% compound annual growth rate (CAGR), from $3.43M to $1.92M.
- What does reportable segment — stock compensation mean?
- The non-cash expense recognized for equity-based awards granted to employees within the reportable segment. This metric provides insight into the company's strategy for talent retention and alignment of employee interests with long-term shareholder value.